Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ALDORO RESOURCES LIMITED Director's Dealing 2025

Jan 30, 2025

64422_rns_2025-01-30_cccfe7f7-8412-4066-9277-a2e178134de3.pdf

Director's Dealing

Open in viewer

Opens in your device viewer

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity Aldoro Resources Limited
ABN 622 990 809

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

We (the entity) give ASX the following
the director for the purposes of section
information under listing rule 3.19A.2 and as agent for
205G of the Corporations Act.
Name of Director Dr Minlu Fu
Date of last notice 14 January 2025

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest Indirect
Nature of indirect interest
(including registered holder)
Note: Provide details of the circumstances giving rise to the relevant
interest.
Lizeng Pty Ltd_(a Company controlled by Dr_
Fu)
Date of change 31 January 2025
No. of securities held prior to change Indirect

29,838,013 fully paid ordinary shares

3,959,504 ARNO Options
Direct

6,660,000 fully paid ordinary shares

3,165,000 ARNO Options
  • See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

Class 1.
Performance
Rights
(subject
to
milestones)
2. Fully paid ordinary shares
Number acquired n/a – reversal of the conversion of 1,970,000
Performance Rights to ordinary shares
Number disposed n/a – reversal of the conversion of 1,970,000
Performance Rights to ordinary shares
Value/Consideration
Note: If consideration is non-cash, provide details and estimated
valuation
Nil
No. of securities held after change Indirect

27,868,013 fully paid ordinary shares

3,959,504 ARNO Options

1,970,000 Performance Rights
Direct

6,660,000 fully paid ordinary shares

3,165,000 ARNO Options
Nature of change
Example: on-market trade, off-market trade, exercise of options,
issue of securities under dividend reinvestment plan, participation in
buy-back
Reversal of part conversion of Performance
Rights (converted to ordinary shares on 14
January 2025) in accordance with the terms
and conditions of these Performance Rights
(Refer to Schedule 1 of Addendum to Notice of
meeting lodged on 29/10/2024)

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract N/A
Nature of interest N/A
Name of registered holder
(if issued securities)
N/A
Date of change N/A
  • See chapter 19 for defined terms.

Appendix 3Y Page 2

01/01/2011

Appendix 3Y Change of Director’s Interest Notice

No. and class of securities to which
interest related prior to change
Note: Details are only required for a contract in
relation to which the interest has changed
N/A
Interest acquired N/A
Interest disposed N/A
Value/Consideration
Note: If consideration is non-cash, provide details
and an estimated valuation
N/A
Interest after change N/A

Part 3 – +Closed period

Part 3 – +Closed period
Were the interests in the securities or contracts detailed above
traded during a +closed period where prior written clearance was
required?
No
If so, was prior written clearance provided to allow the trade to
proceed during this period?
N/A
If prior written clearance was provided, on what date was this
provided?
N/A
  • See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 3